...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Stent Placement in Four Patients with Hepatic Artery Stenosis or Thrombosis after Liver Transplantation.
【24h】

Stent Placement in Four Patients with Hepatic Artery Stenosis or Thrombosis after Liver Transplantation.

机译:肝移植后肝动脉狭窄或血栓形成的四例患者的支架置入。

获取原文
获取原文并翻译 | 示例

摘要

Hepatic artery stenosis and thrombosis represent dangerous complications of liver transplantation because the associated mortality and morbidity rates are high. In the past, repeat transplantation was considered the first-choice therapy; however, new surgical and interventional revascularization techniques have been suggested recently. Although extensive experience has been acquired with percutaneous transluminal angioplasty (PTA) and fibrinolysis techniques, only sporadic cases of stent placement in the hepatic artery of a transplanted liver have been reported, and no long-term results of this technique are available. In this study, seven stents (five Wallstents and two Palmaz stents) were positioned in four patients (two with stenoses and two with thromboses). Stent placement was performed in three cases after PTA and fibrinolysis, whereas primary stent placement was performed in the fourth. In all cases, technical success was achieved. During 18-25 months of follow-up, all stents proved patent and no patient required another transplantation. Although experience is still limited, the authors' experience indicates that placement of a stent in the hepatic artery in cases of stenosis or thrombosis yields good medium-term success, improving the results obtained by fibrinolysis and PTA and consequently enabling the graft to survive and avoiding the need for repeat transplantation.
机译:肝动脉狭窄和血栓形成是肝移植的危险并发症,因为相关的死亡率和发病率很高。在过去,重复移植被认为是首选疗法。然而,最近已经提出了新的外科和介入血运重建技术。尽管在经皮腔内血管成形术(PTA)和纤维蛋白溶解技术方面已经获得了丰富的经验,但仅报道了散在的情况下将支架放置在移植肝脏的肝动脉中,并且该技术没有长期效果。在这项研究中,在四名患者中放置了七个支架(五个Wallstents支架和两个Palmaz支架)(两个患有狭窄和两个血栓形成)。在PTA和纤维蛋白溶解后的三例中进行了支架置入,而在第四例中进行了主支架置入。在所有情况下,都取得了技术上的成功。在18-25个月的随访期间,所有支架均被证明具有专利权,没有患者需要再次移植。尽管经验仍然有限,但作者的经验表明,在狭窄或血栓形成的情况下将支架置入肝动脉可取得良好的中期成功,改善了通过纤维蛋白溶解和PTA获得的结果,从而使移植物能够存活并避免需要重复移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号